378 related articles for article (PubMed ID: 8446919)
21. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
[TBL] [Abstract][Full Text] [Related]
22. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens.
Marcus MM; Mathé JM; Nomikos GG; Svensson TH
Neuropharmacology; 2001 Mar; 40(4):482-90. PubMed ID: 11249957
[TBL] [Abstract][Full Text] [Related]
23. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
Zhang J; Chiodo LA; Freeman AS
J Pharmacol Exp Ther; 1994 Apr; 269(1):313-21. PubMed ID: 7513359
[TBL] [Abstract][Full Text] [Related]
24. Postnatal lead exposure and MK-801 sensitivity.
Cory-Slechta DA
Neurotoxicology; 1997; 18(1):209-20. PubMed ID: 9216003
[TBL] [Abstract][Full Text] [Related]
25. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
Engberg G; Kling-Petersen T; Nissbrandt H
Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
[TBL] [Abstract][Full Text] [Related]
26. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
27. Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine.
Baron SP; Woods JH
Psychopharmacology (Berl); 1995 Mar; 118(1):42-51. PubMed ID: 7597121
[TBL] [Abstract][Full Text] [Related]
28. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
29. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
Schmidt CJ; Fadayel GM
J Pharmacol Exp Ther; 1996 Jun; 277(3):1541-9. PubMed ID: 8667221
[TBL] [Abstract][Full Text] [Related]
30. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
Grant KA; Colombo G
J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
[TBL] [Abstract][Full Text] [Related]
31. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.
Griffiths MR; Cooper AJ; Barber DJ; Mitchell IJ
Brain Res; 2000 Feb; 855(1):1-10. PubMed ID: 10650124
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
[TBL] [Abstract][Full Text] [Related]
34. Effects of NMDA receptor inhibition by phencyclidine on the neuronal differentiation of PC12 cells.
Lee E; Williams Z; Goodman CB; Oriaku ET; Harris C; Thomas M; Soliman KF
Neurotoxicology; 2006 Jul; 27(4):558-66. PubMed ID: 16580729
[TBL] [Abstract][Full Text] [Related]
35. Different capability of N-methyl-D-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats.
Sagratella S; Pezzola A; Popoli P; Scotti de Carolis AS
Psychopharmacology (Berl); 1992; 109(3):277-82. PubMed ID: 1365627
[TBL] [Abstract][Full Text] [Related]
36. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
Loo PS; Braunwalder AF; Lehmann J; Williams M; Sills MA
Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
[TBL] [Abstract][Full Text] [Related]
37. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.
Jentsch JD; Elsworth JD; Redmond DE; Roth RH
J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635
[TBL] [Abstract][Full Text] [Related]
38. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of inward current evoked by N-methyl-D-aspartate in dopamine neurons in the rat brain slice.
Wu YN; Johnson SW
J Pharmacol Exp Ther; 1996 Nov; 279(2):457-63. PubMed ID: 8930146
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
